Seres Therapeutics (MCRB) Receivables (2019 - 2025)
Historic Receivables for Seres Therapeutics (MCRB) over the last 5 years, with Q3 2025 value amounting to $404000.0.
- Seres Therapeutics' Receivables changed N/A to $404000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $404000.0, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is N/A changed from last year.
- Per Seres Therapeutics' latest filing, its Receivables stood at $404000.0 for Q3 2025.
- In the past 5 years, Seres Therapeutics' Receivables registered a high of $9.0 million during Q1 2025, and its lowest value of $404000.0 during Q3 2025.
- Moreover, its 3-year median value for Receivables was $1.9 million (2021), whereas its average is $2.9 million.
- Data for Seres Therapeutics' Receivables shows a peak YoY increase of 2495.2% (in 2021) and a maximum YoY decrease of 6315.94% (in 2021) over the last 5 years.
- Over the past 3 years, Seres Therapeutics' Receivables (Quarter) stood at $1.2 million in 2021, then skyrocketed by 114.64% to $2.7 million in 2024, then tumbled by 84.94% to $404000.0 in 2025.
- Its Receivables stands at $404000.0 for Q3 2025, versus $9.0 million for Q1 2025 and $2.7 million for Q4 2024.